Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-26
DOI
10.1038/s41467-021-27063-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation
- (2021) Bojan F. Hörnich et al. JOURNAL OF VIROLOGY
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- Heterologous prime-boost: Breaking the protective immune response bottleneck of COVID-19 vaccine candidates
- (2021) Qian He et al. Emerging Microbes & Infections
- Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
- (2021) Sybil Tasker et al. Vaccines
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
- (2021) Matan Levine-Tiefenbrun et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants
- (2021) Ezgi Hacisuleyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
- (2021) Stefania Dispinseri et al. Nature Communications
- ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
- (2021) Glenn A. Marsh et al. npj Vaccines
- BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
- (2021) Tal Brosh-Nissimov et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2021) Alberto M Borobia et al. LANCET
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
- (2021) Matthias Tenbusch et al. LANCET INFECTIOUS DISEASES
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
- (2021) Talia Kustin et al. NATURE MEDICINE
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
- (2021) Robert W. Frenck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
- (2021) Johan Normark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
- (2021) Ross J. Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence for antibody as a protective correlate for COVID-19 vaccines
- (2021) Kristen A. Earle et al. VACCINE
- A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
- (2021) Traci L. Bricker et al. Cell Reports
- SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
- (2021) Markus Hoffmann et al. Cell Reports
- Human Immune Responses Elicited by an Intranasal Inactivated H5 Influenza Vaccine
- (2020) Akira Ainai et al. MICROBIOLOGY AND IMMUNOLOGY
- Prevention of tuberculosis in macaques after intravenous BCG immunization
- (2020) Patricia A. Darrah et al. NATURE
- Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes
- (2020) Kosuke Okuya et al. JOURNAL OF VIROLOGY
- Detection of SARS-CoV-2 in human breastmilk
- (2020) Rüdiger Groß et al. LANCET
- Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine
- (2020) Dennis Lapuente et al. PLoS One
- Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study
- (2020) Olga Pleguezuelos et al. npj Vaccines
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
- (2020) Dennis Lapuente et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- Growth, detection, quantification, and inactivation of SARS-CoV-2
- (2020) James Brett Case et al. VIROLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8+ Memory T Cells
- (2019) Nicolas Çuburu et al. JOURNAL OF IMMUNOLOGY
- Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus
- (2019) Myung Hee Kim et al. PLoS One
- Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection
- (2019) Aleks Guvenel et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses
- (2018) D. Lapuente et al. Mucosal Immunology
- Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses
- (2018) Simone L. Park et al. NATURE IMMUNOLOGY
- Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses
- (2018) Dennis Lapuente et al. VACCINE
- IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration
- (2018) Yoshihiko Terauchi et al. Human Vaccines & Immunotherapeutics
- Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre
- (2017) Victoria M. W. Gould et al. Frontiers in Microbiology
- Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1 + Dendritic Cells
- (2016) Salvador Iborra et al. IMMUNITY
- Specific niches for lung-resident memory CD8 + T cells at the site of tissue regeneration enable CD69-independent maintenance
- (2016) Shiki Takamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes
- (2016) L. K. Mackay et al. SCIENCE
- RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
- (2015) Agnieszka Jozwik et al. Nature Communications
- Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma-Homing CD4 T Cells
- (2014) S. Sakai et al. JOURNAL OF IMMUNOLOGY
- Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans
- (2014) A. Morokutti et al. VACCINE
- Lung-resident memory CD8 T cells (TRM ) are indispensable for optimal cross-protection against pulmonary virus infection
- (2013) Tao Wu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Sensing and alarm function of resident memory CD8+ T cells
- (2013) Jason M Schenkel et al. NATURE IMMUNOLOGY
- Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
- (2013) Akira Ainai et al. Human Vaccines & Immunotherapeutics
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Cutting Edge: Intravascular Staining Redefines Lung CD8 T Cell Responses
- (2012) K. G. Anderson et al. JOURNAL OF IMMUNOLOGY
- The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain
- (2012) L. M. Wakim et al. JOURNAL OF IMMUNOLOGY
- Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
- (2012) H. Li et al. JOURNAL OF VIROLOGY
- The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
- (2012) Christopher S. Ambrose et al. VACCINE
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
- (2011) J. R. Teijaro et al. JOURNAL OF IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now